NCT03574623Completed
Therapies for Recovery of Hand Function After Stroke
Contralaterally Controlled FES Versus Cyclic NMES for Hand Function After Stroke
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
After a stroke, it is very common to lose the ability to open the affected hand. The purpose of this study is to compare the effects of three different therapies on recovery of hand function after stroke and determine if any one is better than the other.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 132 (actual)
- First submitted
- 20 Jun 2018
- Start date
- 15 Feb 2019
- Primary completion date
- 16 Oct 2024
- Lead sponsor
- MetroHealth Medical Center
- Diseases
- Stroke
- NCT number
- NCT03574623
What you commit to
- Study type: Interventional
- Participants enrolled: 132
- From 15 Feb 2019 to the primary completion date, 16 Oct 2024
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- concurrent enrollment in another investigational study
Other illness
- co-existing neurologic diagnosis of peripheral nerve injury, Parkinson's disease, spinal cord injury, traumatic brain injury, or multiple sclerosis
- uncontrolled seizure disorder
- brainstem stroke
- history of potentially fatal cardiac arrhythmias with hemodynamic instability
- diagnosis (apart from stroke) that substantially affects paretic arm and hand function
Other
- uncompensated hemineglect
- severe shoulder or hand pain
- insensate forearm or hand
- implanted electronic systems (e.g. pacemaker)
- botulinum toxin injections to any upper extremity muscle within 3 months of enrolling
- pregnant women due to unknown risks of surface NMES during pregnancy
- lack of functional passive range of motion of the wrist or fingers of affected side
- deficits in communication that interfere with reasonable study participation
- lacking sufficient visual acuity to see the stimulator's display
Who the study is looking for
- 6 to 24 months since a first clinical cortical or subcortical, hemorrhagic or nonhemorrhagic stroke
- unilateral upper limb hemiparesis with finger extensor strength of grade no more than 4 out of 5 on the Medical Research Council (MRC) scale
- score of at least 1 and no more than 11 out of 14 on the hand section of the upper extremity Fugl-Meyer Assessment
- adequate active movement of the shoulder and elbow to position the hand in the workspace for table-top task practice (necessary for the lab task practice sessions)
- able to follow 3-stage commands
- able to recall at least 2 of a list of 3 items after 30 minutes
- skin intact on the hemiparetic arm
- surface stimulation of the paretic finger and thumb extensors produces functional hand opening without pain (this will exclude those who have too much flexor spasticity)
- able to hear and respond to cues from stimulator
- not receiving occupational therapy (no concomitant OT)
- full voluntary opening/closing of the contralateral (less affected) hand
- demonstrates ability to follow instructions for operating the stimulator or have a caregiver who will assist them
Age in the registry: 21 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Emory University and Atlanta VA Coordinator of this site? Confirm its status | Atlanta | United States | Unknown status |
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
| MetroHealth Rehabilitation Institute Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
| Kessler Foundation Coordinator of this site? Confirm its status | West Orange | United States | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.